ctDNA for Minimal Disease Research by Hybridization Capture in Resected Cancer Samples

Explore how hybridization capture solutions are revolutionizing circulating tumor DNA (ctDNA) research for minimal residual disease (MRD) in this 17-minute webinar by Integrated DNA Technologies (IDT). Gain valuable insights into the significance of MRD research, its advantages over traditional methods, and its role in discovering new biomarkers. Understand how IDT's technology is helping researchers overcome challenges in ctDNA analysis for resected cancer samples. Discover the potential for new collaborations and breakthroughs in oncology research as these innovative studies are brought to the forefront. For more information, visit https://idtb.io/bmru7r.